Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

David Kao

Concepts (373)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Heart Failure
35
2026
2314
4.980
Why?
Machine Learning
8
2025
585
2.250
Why?
Stroke Volume
17
2025
648
1.900
Why?
Adrenergic beta-Antagonists
10
2025
250
1.540
Why?
Methadone
5
2023
110
1.460
Why?
Pregnancy Complications, Cardiovascular
5
2022
83
1.430
Why?
Buprenorphine
3
2023
181
1.330
Why?
Cardiomyopathies
5
2022
337
1.310
Why?
United States Food and Drug Administration
5
2024
203
1.210
Why?
Decision Support Systems, Clinical
6
2024
265
1.160
Why?
Pharmacogenetics
5
2024
172
1.120
Why?
Cardiomyopathy, Dilated
9
2025
359
1.120
Why?
Adverse Drug Reaction Reporting Systems
4
2024
81
1.080
Why?
Arrhythmias, Cardiac
6
2023
360
1.050
Why?
Cytochrome P-450 CYP2C19
4
2024
26
0.970
Why?
Electronic Health Records
7
2024
1169
0.960
Why?
Propanolamines
3
2019
40
0.900
Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
2
2024
434
0.860
Why?
Hospitalization
10
2024
2424
0.840
Why?
Workflow
2
2026
184
0.830
Why?
Telemedicine
4
2024
940
0.750
Why?
Atrial Fibrillation
5
2026
548
0.740
Why?
Torsades de Pointes
4
2016
23
0.720
Why?
Seasons
1
2024
556
0.710
Why?
Pulmonary Edema
1
2021
106
0.690
Why?
Humans
88
2026
144261
0.690
Why?
Coffee
1
2021
15
0.670
Why?
Pharmacogenomic Testing
4
2022
62
0.650
Why?
Stroke
2
2021
1254
0.630
Why?
Platelet Aggregation Inhibitors
1
2024
497
0.630
Why?
Aged
33
2026
25850
0.610
Why?
Defibrillators, Implantable
2
2021
382
0.610
Why?
Artificial Intelligence
2
2026
365
0.600
Why?
Prosthesis Failure
1
2020
125
0.590
Why?
Prosthesis-Related Infections
1
2020
99
0.580
Why?
Long QT Syndrome
3
2016
69
0.580
Why?
Mobile Applications
1
2021
196
0.580
Why?
Spironolactone
1
2019
39
0.570
Why?
Device Removal
1
2020
142
0.570
Why?
Risk Assessment
10
2026
3637
0.570
Why?
United States
22
2025
15876
0.570
Why?
Pacemaker, Artificial
1
2020
126
0.560
Why?
Medical Records
2
2019
186
0.560
Why?
Coronary Disease
1
2021
381
0.560
Why?
Mineralocorticoid Receptor Antagonists
1
2019
68
0.550
Why?
Diabetes Mellitus
2
2024
1092
0.550
Why?
Biomedical Research
2
2024
709
0.540
Why?
Periodicals as Topic
1
2020
203
0.540
Why?
Mortality
3
2019
371
0.530
Why?
Retrospective Studies
22
2026
17009
0.530
Why?
Hypertension, Pregnancy-Induced
1
2018
67
0.510
Why?
Female
50
2026
77976
0.500
Why?
Receptors, Transforming Growth Factor beta
1
2017
57
0.500
Why?
Hospital Records
1
2016
10
0.490
Why?
Proteoglycans
1
2017
108
0.490
Why?
Ventricular Function, Left
5
2025
538
0.480
Why?
Analgesics, Opioid
2
2023
1131
0.480
Why?
Hospital Mortality
6
2024
1027
0.470
Why?
Disease Management
1
2020
643
0.460
Why?
Survival
1
2015
38
0.460
Why?
Tetrazoles
1
2015
50
0.450
Why?
Male
42
2026
72035
0.450
Why?
Middle Aged
30
2025
35762
0.450
Why?
Electrocardiography
5
2026
660
0.450
Why?
Biphenyl Compounds
1
2015
68
0.440
Why?
Muscle Proteins
2
2025
244
0.440
Why?
Myocardial Infarction
3
2018
1208
0.420
Why?
Research Design
1
2020
1129
0.420
Why?
Ventricular Remodeling
3
2025
275
0.410
Why?
Loperamide
2
2023
12
0.400
Why?
Myocardium
3
2017
939
0.390
Why?
Diet
1
2021
1271
0.390
Why?
Polymorphism, Single Nucleotide
4
2017
2143
0.390
Why?
Tachycardia, Ventricular
1
2015
181
0.380
Why?
Registries
2
2020
2382
0.380
Why?
Precision Medicine
6
2024
456
0.380
Why?
Adult
28
2024
40262
0.370
Why?
Legislation, Medical
1
2012
11
0.370
Why?
Amiodarone
1
2012
31
0.370
Why?
Peripartum Period
4
2022
19
0.370
Why?
Phenotype
5
2025
3157
0.360
Why?
Patient Readmission
1
2018
756
0.360
Why?
Quality Improvement
2
2020
1285
0.350
Why?
Anti-Arrhythmia Agents
1
2012
141
0.340
Why?
Sex Factors
4
2024
2096
0.330
Why?
Pyrazines
2
2008
92
0.330
Why?
Catheter Ablation
1
2015
353
0.330
Why?
Heart Arrest
4
2019
407
0.330
Why?
Cardiovascular Diseases
5
2024
2134
0.330
Why?
Treatment Outcome
10
2025
11643
0.320
Why?
Transfusion Reaction
1
2011
63
0.320
Why?
Forecasting
2
2024
388
0.320
Why?
Triazoles
2
2008
184
0.320
Why?
Heart-Assist Devices
1
2016
567
0.320
Why?
Echocardiography
3
2024
647
0.320
Why?
Risk Factors
10
2025
10699
0.310
Why?
Postoperative Complications
2
2020
2916
0.300
Why?
Insurance, Health
1
2012
301
0.300
Why?
Patient Discharge
2
2021
977
0.300
Why?
Patient Transfer
1
2012
206
0.300
Why?
Anemia
1
2011
187
0.290
Why?
Thiazolidinediones
1
2010
138
0.290
Why?
Databases, Factual
5
2020
1484
0.290
Why?
Genotype
3
2024
1833
0.290
Why?
Marketing
1
2008
24
0.290
Why?
Rhabdomyolysis
1
2008
23
0.280
Why?
Renal Insufficiency
1
2011
168
0.280
Why?
Drug Industry
1
2008
48
0.280
Why?
Aged, 80 and over
7
2024
8243
0.280
Why?
Simvastatin
1
2008
59
0.280
Why?
Heart Ventricles
4
2017
756
0.280
Why?
Receptors, Adrenergic, beta-1
4
2019
23
0.280
Why?
Dipeptidyl-Peptidase IV Inhibitors
1
2008
46
0.280
Why?
Incidence
6
2025
2870
0.280
Why?
Heart Rate
3
2025
849
0.270
Why?
Follow-Up Studies
7
2025
5389
0.270
Why?
Length of Stay
4
2024
1335
0.260
Why?
Cytochrome P-450 CYP2D6
3
2022
32
0.260
Why?
Kaplan-Meier Estimate
3
2016
964
0.260
Why?
Proportional Hazards Models
4
2021
1322
0.260
Why?
Pharmacovigilance
2
2024
23
0.250
Why?
Practice Patterns, Physicians'
3
2020
1347
0.250
Why?
Elective Surgical Procedures
2
2020
201
0.240
Why?
Biological Specimen Banks
3
2024
101
0.240
Why?
Atrial Flutter
1
2026
45
0.230
Why?
Gene Expression Regulation
1
2015
2603
0.230
Why?
Emergency Service, Hospital
2
2020
2301
0.230
Why?
Patient Reported Outcome Measures
2
2020
487
0.220
Why?
Cause of Death
2
2019
464
0.220
Why?
New York
1
2024
124
0.210
Why?
Glucose
1
2010
1046
0.210
Why?
Diabetic Cardiomyopathies
1
2024
34
0.210
Why?
Pandemics
3
2022
1682
0.210
Why?
Young Adult
9
2022
13990
0.200
Why?
Pregnancy
6
2022
7180
0.200
Why?
Diphenoxylate
1
2023
5
0.200
Why?
Acute Kidney Injury
2
2008
862
0.200
Why?
Randomized Controlled Trials as Topic
3
2021
1705
0.190
Why?
Adolescent
10
2020
22281
0.190
Why?
Nonprescription Drugs
1
2023
65
0.190
Why?
Monitoring, Physiologic
1
2024
289
0.190
Why?
Heart Defects, Congenital
2
2020
913
0.180
Why?
Prognosis
5
2020
4278
0.180
Why?
Medicare
2
2020
881
0.180
Why?
Algorithms
4
2025
1834
0.180
Why?
Naltrexone
1
2023
117
0.180
Why?
Insulin Resistance
1
2010
1232
0.170
Why?
Speech
1
2021
77
0.170
Why?
Red Meat
1
2021
17
0.170
Why?
Hypertension
2
2020
1254
0.170
Why?
Time Factors
3
2020
7155
0.170
Why?
Losartan
1
2020
13
0.170
Why?
Lisinopril
1
2020
15
0.170
Why?
Drug Dosage Calculations
1
2020
27
0.170
Why?
Data Interpretation, Statistical
2
2020
371
0.170
Why?
Protective Factors
1
2021
99
0.160
Why?
Smartphone
1
2021
102
0.160
Why?
Angioedema
1
2020
15
0.160
Why?
Actigraphy
1
2021
145
0.160
Why?
Cardiac Resynchronization Therapy
1
2021
63
0.160
Why?
Wearable Electronic Devices
1
2021
63
0.160
Why?
American Heart Association
2
2019
348
0.160
Why?
Milk
1
2021
119
0.160
Why?
Hypoglycemic Agents
1
2010
1379
0.160
Why?
Turner Syndrome
1
2021
63
0.160
Why?
Data Accuracy
1
2020
65
0.160
Why?
Indans
1
2020
13
0.160
Why?
Biological Products
1
2023
251
0.160
Why?
Oxadiazoles
1
2020
37
0.160
Why?
Bionics
1
2019
14
0.160
Why?
Editorial Policies
1
2020
46
0.160
Why?
California
2
2012
469
0.160
Why?
Medical Informatics
1
2020
97
0.150
Why?
Referral and Consultation
2
2017
847
0.150
Why?
Fingolimod Hydrochloride
1
2020
39
0.150
Why?
Medical Futility
1
2019
31
0.150
Why?
Medical Record Linkage
1
2020
68
0.150
Why?
Software
2
2015
690
0.150
Why?
Prescription Drugs
1
2020
110
0.150
Why?
Information Storage and Retrieval
1
2020
121
0.150
Why?
Drug Overdose
1
2023
367
0.140
Why?
Multiple Sclerosis, Relapsing-Remitting
1
2020
82
0.140
Why?
Sitagliptin Phosphate
2
2008
31
0.140
Why?
Medical Order Entry Systems
1
2019
40
0.140
Why?
Drug Prescriptions
1
2021
280
0.140
Why?
Dose-Response Relationship, Drug
4
2020
2026
0.140
Why?
Child Health Services
1
2020
185
0.140
Why?
Tobacco Use
1
2019
61
0.140
Why?
Cohort Studies
3
2021
5935
0.140
Why?
Computer Graphics
2
2015
41
0.140
Why?
Cluster Analysis
1
2019
519
0.140
Why?
Social Determinants of Health
1
2022
299
0.140
Why?
Receptors, Histamine H2
1
2017
6
0.140
Why?
Gene Regulatory Networks
2
2023
318
0.130
Why?
Florida
1
2018
116
0.130
Why?
Advisory Committees
1
2019
227
0.130
Why?
Neisseria gonorrhoeae
1
1997
29
0.130
Why?
Porins
1
1997
18
0.130
Why?
Dyslipidemias
1
2019
171
0.130
Why?
Consensus
1
2019
488
0.130
Why?
Prospective Studies
4
2021
7970
0.130
Why?
Nursing Assessment
1
2017
56
0.130
Why?
Academic Medical Centers
1
2020
545
0.120
Why?
Pressure Ulcer
1
2017
43
0.120
Why?
Patient Participation
1
2020
429
0.120
Why?
Antihypertensive Agents
1
2020
509
0.120
Why?
Population Surveillance
1
2020
483
0.120
Why?
Heart Diseases
1
2020
349
0.120
Why?
Hospitals, Teaching
1
2017
119
0.120
Why?
Tilidine
1
2016
2
0.120
Why?
Cardiology
1
2019
353
0.120
Why?
Genetic Markers
1
2017
331
0.120
Why?
Double-Blind Method
3
2025
2025
0.120
Why?
Oxycodone
1
2016
53
0.120
Why?
Rheumatic Fever
1
2015
5
0.110
Why?
Rheumatic Heart Disease
1
2015
4
0.110
Why?
Databases, Genetic
1
2017
248
0.110
Why?
Sex Distribution
1
2016
380
0.110
Why?
Angiotensin II Type 1 Receptor Blockers
1
2015
38
0.110
Why?
Cholesterol Ester Transfer Proteins
1
2015
22
0.110
Why?
Angiotensin II
1
2015
97
0.110
Why?
Hospitals, Low-Volume
1
2015
25
0.110
Why?
Immunosuppressive Agents
1
2020
846
0.110
Why?
Gene Expression Profiling
3
2017
1782
0.110
Why?
Oligonucleotide Array Sequence Analysis
1
2017
758
0.110
Why?
Hospitals, High-Volume
1
2015
49
0.110
Why?
Computational Biology
2
2017
680
0.110
Why?
Naloxone
1
2016
132
0.110
Why?
Marijuana Use
1
2018
213
0.110
Why?
Mothers
1
2020
774
0.110
Why?
United Kingdom
1
2015
336
0.110
Why?
Percutaneous Coronary Intervention
1
2020
543
0.100
Why?
Biomarkers
2
2024
4254
0.100
Why?
International Classification of Diseases
1
2015
143
0.100
Why?
Age Factors
2
2019
3313
0.100
Why?
Comorbidity
1
2019
1646
0.100
Why?
Chronic Disease
2
2020
1812
0.100
Why?
Gene Expression
2
2017
1487
0.100
Why?
Down-Regulation
1
2015
627
0.100
Why?
MicroRNAs
2
2017
700
0.100
Why?
Cholesterol
1
2015
399
0.100
Why?
Narcotic Antagonists
1
2015
204
0.100
Why?
Ventricular Dysfunction, Left
2
2020
390
0.100
Why?
Federal Government
1
2012
23
0.090
Why?
Coronary Artery Disease
1
2019
741
0.090
Why?
Myocytes, Cardiac
1
2017
551
0.090
Why?
Drug Resistance
1
2012
153
0.090
Why?
RNA, Messenger
2
2017
2829
0.090
Why?
Area Under Curve
1
2012
329
0.090
Why?
Genetic Predisposition to Disease
2
2017
2359
0.090
Why?
Pulmonary Disease, Chronic Obstructive
1
2019
919
0.090
Why?
Colorado
4
2024
4562
0.090
Why?
Predictive Value of Tests
1
2017
2111
0.080
Why?
Patient Safety
1
2015
347
0.080
Why?
Anti-Retroviral Agents
1
2013
240
0.080
Why?
Gastrointestinal Hemorrhage
1
2012
136
0.080
Why?
Opiate Substitution Treatment
1
2013
174
0.080
Why?
Bayes Theorem
1
2012
433
0.080
Why?
Managed Care Programs
2
2022
136
0.080
Why?
Survival Rate
1
2015
2088
0.080
Why?
Pregnancy Outcome
1
2013
476
0.080
Why?
Endoscopy, Gastrointestinal
1
2012
237
0.080
Why?
Genome-Wide Association Study
1
2017
1406
0.080
Why?
Delivery of Health Care
1
2017
940
0.080
Why?
Multivariate Analysis
1
2012
1533
0.070
Why?
Severity of Illness Index
1
2017
2917
0.070
Why?
Pharmacogenomic Variants
2
2019
33
0.070
Why?
Primary Health Care
1
2019
1710
0.070
Why?
Drug Approval
1
2008
89
0.070
Why?
Emergency Medical Services
1
2015
696
0.070
Why?
Vasodilator Agents
1
2010
331
0.070
Why?
Logistic Models
1
2012
2104
0.060
Why?
Kidney Function Tests
1
2007
157
0.060
Why?
Animals
3
2023
38030
0.060
Why?
Drug-Related Side Effects and Adverse Reactions
1
2008
257
0.060
Why?
Zimbabwe
2
2017
74
0.060
Why?
Drug Therapy, Combination
1
2008
1044
0.060
Why?
Reproducibility of Results
2
2026
3403
0.060
Why?
Opioid-Related Disorders
1
2013
576
0.060
Why?
Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels
1
2025
36
0.050
Why?
Models, Biological
1
2012
1820
0.050
Why?
Case-Control Studies
1
2012
3592
0.050
Why?
Canada
1
2026
428
0.050
Why?
Psychological Tests
1
2005
131
0.050
Why?
Potassium Channels
1
2025
145
0.050
Why?
Osteoporosis, Postmenopausal
1
2004
40
0.050
Why?
Mandible
1
2004
72
0.050
Why?
Depression
2
2022
1533
0.050
Why?
Cross-Sectional Studies
3
2022
5813
0.050
Why?
Receptors, Adrenergic
1
2023
20
0.050
Why?
Drug Administration Schedule
2
2020
778
0.050
Why?
Cardiovascular Agents
1
2025
163
0.050
Why?
Carcinoembryonic Antigen
1
2002
38
0.050
Why?
Antigens, Differentiation
1
2002
77
0.050
Why?
Child
5
2020
22537
0.040
Why?
Antigens, Bacterial
1
2002
125
0.040
Why?
Electronic Prescribing
1
2021
3
0.040
Why?
Cell Adhesion Molecules
1
2002
177
0.040
Why?
Vitamin K Epoxide Reductases
1
2020
11
0.040
Why?
Health Services Misuse
1
2020
35
0.040
Why?
Antigens, Neoplasm
1
2002
271
0.040
Why?
Insurance Claim Reporting
1
2020
25
0.040
Why?
Antidepressive Agents
1
2022
242
0.040
Why?
Lymphocyte Count
1
2020
164
0.040
Why?
Morbidity
1
2020
323
0.040
Why?
Membrane Glycoproteins
1
2002
496
0.040
Why?
Metoprolol
1
2019
26
0.040
Why?
Antineoplastic Agents
1
2010
2192
0.040
Why?
Grounded Theory
1
2019
46
0.040
Why?
Bias
1
2020
201
0.040
Why?
Aftercare
1
2020
220
0.040
Why?
Antigens, CD
1
2002
555
0.040
Why?
Genomics
1
2024
833
0.030
Why?
Mice, Transgenic
1
2023
2182
0.030
Why?
Coronary Angiography
1
2020
322
0.030
Why?
HIV Infections
1
2013
3079
0.030
Why?
Amino Acid Sequence
2
2002
2154
0.030
Why?
Delivery of Health Care, Integrated
1
2020
297
0.030
Why?
Static Electricity
1
1997
113
0.030
Why?
Molecular Sequence Data
2
2002
2929
0.030
Why?
Exercise Test
1
2020
634
0.030
Why?
Tomography, Emission-Computed, Single-Photon
1
2017
103
0.030
Why?
Inpatients
1
2021
542
0.030
Why?
Frail Elderly
1
2017
133
0.030
Why?
Focus Groups
1
2019
569
0.030
Why?
Socioeconomic Factors
1
2020
1312
0.030
Why?
Real-Time Polymerase Chain Reaction
1
2017
341
0.030
Why?
World Health Organization
1
2016
103
0.030
Why?
Metabolic Networks and Pathways
1
2017
187
0.030
Why?
Puerperal Disorders
1
2016
37
0.030
Why?
Physician-Patient Relations
1
2020
581
0.030
Why?
Neoplasms
1
2010
2870
0.030
Why?
Decision Trees
1
2015
81
0.030
Why?
Drug Combinations
1
2016
390
0.030
Why?
Data Mining
1
2015
117
0.030
Why?
Blood Pressure
1
2020
1759
0.030
Why?
Cell Membrane
1
1997
706
0.020
Why?
Biopsy
1
2017
1075
0.020
Why?
Pediatrics
1
2020
1112
0.020
Why?
Models, Genetic
1
2015
535
0.020
Why?
Mass Screening
2
2013
1332
0.020
Why?
Liver
1
2020
1884
0.020
Why?
Infant
2
2015
10022
0.020
Why?
Anthracyclines
1
2010
47
0.020
Why?
Child, Preschool
2
2015
11774
0.020
Why?
Trastuzumab
1
2010
118
0.020
Why?
Angiotensin Receptor Antagonists
1
2010
114
0.020
Why?
Signal Transduction
1
2023
5221
0.020
Why?
Clinical Trials as Topic
1
2015
1050
0.020
Why?
Angiotensin-Converting Enzyme Inhibitors
1
2010
221
0.020
Why?
Program Evaluation
1
2013
946
0.020
Why?
Apoptosis
1
2017
2430
0.020
Why?
Injections, Intravenous
1
2007
200
0.020
Why?
Natriuretic Peptide, Brain
1
2007
109
0.020
Why?
Ultrasonography
1
2010
768
0.020
Why?
Infusions, Intravenous
1
2007
423
0.020
Why?
Mice
1
2023
18329
0.010
Why?
Creatinine
1
2007
505
0.010
Why?
Hospitals, University
1
2005
176
0.010
Why?
Dentists
1
2004
21
0.010
Why?
Antibodies, Monoclonal, Humanized
1
2010
985
0.010
Why?
Femur Neck
1
2004
62
0.010
Why?
Bone Diseases, Metabolic
1
2004
56
0.010
Why?
Absorptiometry, Photon
1
2004
275
0.010
Why?
Antibodies, Monoclonal
1
2010
1519
0.010
Why?
Nurses
1
2005
178
0.010
Why?
Heparan Sulfate Proteoglycans
1
2002
24
0.010
Why?
Analysis of Variance
1
2004
1304
0.010
Why?
Bone Density
1
2004
482
0.010
Why?
HeLa Cells
1
2002
650
0.010
Why?
Binding Sites
1
2002
1327
0.010
Why?
Clinical Competence
1
2005
1241
0.010
Why?
Physicians
1
2005
938
0.010
Why?
Kao's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)